Skip to main content
SKINBIOTHERAPEUTICS PLC logo

SKINBIOTHERAPEUTICS PLC — Investor Relations & Filings

Ticker · SBTX ISIN · GB00BF33H870 LEI · 213800YMQOCB23FX6I06 IL Manufacturing
Open in API
Filings indexed 315 across all filing types
Latest filing 2025-02-24 Declaration of Voting R…
Country GB United Kingdom
Listing IL SBTX

About SKINBIOTHERAPEUTICS PLC

https://www.skinbiotherapeutics.com/

SkinBioTherapeutics PLC is a life science company focused on advancing skin health by harnessing the human microbiome. Its proprietary SkinBiotix® platform technology utilizes probiotic lysates to protect, manage, and restore skin. The company develops and commercializes products across several healthcare sectors, including cosmetics, food supplements, medical devices, and pharmaceuticals. Key offerings include AxisBiotix, a probiotic food supplement designed to address psoriasis symptoms, and the Dermatonics line of specialized foot care products. Through its acquisition of Bio-Tech Solutions, the company also provides formulation, manufacturing, and packaging services for healthcare, personal care, and hygiene products.

Recent filings

Filing Released Lang Actions
Exercise of Warrants and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is clearly identified as an 'RNS Number' release from 'SkinBioTherapeutics plc' dated February 24, 2025. The content discusses the 'Exercise of Warrants and Total Voting Rights' and the subsequent admission of new shares, which directly impacts the total voting rights denominator used by shareholders for disclosure purposes. This type of announcement, which is a formal regulatory update concerning share capital changes and voting rights, fits best under the category dealing with significant shareholding notifications or general regulatory announcements. Since it specifically details a change in the total number of shares and voting rights (a key component of major shareholding notifications), and is distributed via RNS, it aligns closely with 'Major Shareholding Notification' (MRQ) or the general 'Regulatory Filings' (RNS). Given the focus on the total voting rights denominator update following a share issuance event (warrant exercise), MRQ is a strong candidate, but the core event is the issuance/capital change leading to the voting rights update. However, the most precise fit among the options for an announcement detailing the total voting rights figure (denominator) is often captured under general regulatory updates or specific share/capital change notifications. Since it involves the issuance of new shares (SHA) and the resulting voting rights update (MRQ), and is distributed as a standard RNS announcement, RNS serves as the most appropriate general regulatory filing category if a more specific one isn't perfect. Let's re-evaluate: It announces the exercise of warrants leading to new shares, which is a 'Share Issue/Capital Change' (SHA). It also announces the resulting 'Total Voting Rights' figure, which is crucial for 'Major Shareholding Notification' (MRQ). Since the primary action is the capital change (warrant exercise) and the resulting voting rights update is a consequence reported under the RNS system, RNS is the safest general classification, but SHA is also highly relevant. Given the explicit mention of the 'Total Voting Rights' denominator update, which is a key feature of MRQ filings, and the fact that it's a standard RNS announcement, I will classify it as RNS as it is a general regulatory announcement detailing a corporate action.
2025-02-24 English
Result of AGM
AGM Information Classification · 99% confidence The document is a short announcement (3533 characters) released via RNS (RNS Number: 4635R) on December 27, 2024. The title explicitly states 'Result of Annual General Meeting'. It confirms that 'all resolutions were passed' at the AGM. This directly relates to the outcome of a shareholder meeting. While it mentions the Annual Report and Notice of AGM, the core content is the result of the meeting itself. This fits the definition of 'AGM Information' (AGM-R) better than a general regulatory filing (RNS) or a declaration of voting results (DVA), as it is the official communication regarding the meeting's conclusion, not just the vote tally or the proxy materials. Given the context of reporting the outcome of the AGM, AGM-R is the most precise fit.
2024-12-27 English
Group of companies' accounts made up to 2024-06-30
Regulatory Filings
2024-12-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields typical of regulatory filings concerning share ownership changes, such as 'Identity of the issuer', 'Reason for the notification', 'Date on which the threshold was crossed or reached', and 'Total positions of person(s) subject to the notification obligation'. The RNS Number (9122P) and reference to the FCA confirm it is a regulatory disclosure. This type of filing, reporting changes in significant shareholdings (crossing thresholds), maps directly to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-12-12 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement Classification · 100% confidence The document is a short announcement (3548 characters) released via RNS (London Stock Exchange news service). The title explicitly states "Posting of Annual Report and AGM Notice". It confirms that the Annual Report and Accounts for the year ended 30 June 2024, along with the Notice of AGM, have been posted to shareholders and are available on the website. According to Rule 2 (The "MENU VS MEAL" RULE), when a document announces the publication or posting of a report (like the Annual Report or AGM Notice) rather than containing the full report itself, it should be classified as a Report Publication Announcement (RPA). Since this document is an announcement about the posting of the Annual Report and the AGM Notice, RPA is the most appropriate classification.
2024-12-04 English
Final Results
Annual Report Classification · 95% confidence The document is a comprehensive 'Full Year results' announcement for SkinBioTherapeutics PLC for the year ended 30 June 2024. It contains detailed operational highlights, financial highlights (revenue, operating loss, cash position), a Chairman's Statement, and a Strategic and Financial Review. While it is distributed via an RNS (Regulatory News Service) feed, it constitutes the actual annual financial results report rather than a mere announcement of a report's availability. Therefore, it is classified as an Annual Report (10-K equivalent for this jurisdiction). FY 2024
2024-12-04 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.